SAMARITAN TO BULK UP ITS BUDDING HIV DRUG MARKETING EFFORTS

Samaritan Pharmaceuticals Inc. (AMEX:LIV), a developer of innovative drugs, announced today its strategy to build a European marketing and sales engine to transform the economic performance of the Company. Samaritan is establishing its European headquarters in Athens, Greece, which allows access to the markets of Eastern Europe, Asia and Africa; regions with a high proportion of HIV patients, a target population for our most advanced drug SP01A, which is in phase II/III studies. Samaritan Europe is swiftly implementing its marketing infrastructure in Greece, South and Eastern Europe to develop and market SP01A.

Business Wire (http://home.businesswire.com/portal/site/google/index.jsp?ndmViewId=news_view&newsId=20051024005507&newsLang=en)